Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis
Frontiers in endocrinology, 2026;17:1903335
Peptides in Aesthetic Dermatology: Classification, Fibroblast-Centered Mechanisms, Delivery Technologies, and Clinical Evidence
Life (Basel, Switzerland), 2026;16(10)
Intramuscular Fat as a Biomarker of Muscle Health: Strengths, Limitations and Open Challenges
Journal of cachexia, sarcopenia and muscle;17(5):e70389
Weight gain, adipose tissue remodeling and cardiometabolic disease in people with HIV
Current opinion in HIV and AIDS, 2026;21(6):480-487
Interactions of Glucagon-Like Peptide-1 Receptor Agonists With GLP-1R-Gs Complex: Insights From Gaussian-Accelerated Molecular Dynamics
Proteins, 2026
Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial
Nature medicine, 2026
Tirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues
BMJ open, 2026;16(10):e120507
Retatrutide trial: Triple action jab can cause weight loss of up to 25%, results suggest
BMJ (Clinical research ed.), 2026;395:e101016
GLP-1 receptor agonists in psoriasis management
Clinics in dermatology, 2026
The effect of submaximal doses of semaglutide on the expression of micro-RNA in patients with obesity: a pilot study
Obesity facts, 2026;:1
Beyond metabolic control: the potential role of antidiabetic therapies in modulating male reproductive function and spermatogenesis
Reviews in endocrine & metabolic disorders, 2026
Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity
JAMA network open, 2026;9(10):e2637779
Current review of glucagon-like peptide 1 receptor agonists and risk of nonarteritic anterior ischemic optic neuropathy
Journal of the Endocrine Society, 2026;10(11):bvag224
Self-Reported Adverse Effects Among Social Media Users Taking Nonapproved Retatrutide
JAMA network open, 2026;9(10):e2638929
Effects of Blueberry and Collard Greens Dietary Intervention on Metabolic and Inflammatory Biomarkers in Zucker Obese Rats
Nutrients, 2026;18(19)
Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review
Pharmaceuticals (Basel, Switzerland), 2026;19(10)
Perioperative management of patients taking GLP-1 receptor agonists: A comparative review of international clinical guidelines
Saudi journal of anaesthesia, 2026;20(4):983-991
Non-ST Elevation Myocardial Infarction Following Significant Weight Loss During Tirzepatide Therapy: A Case Report
Cureus, 2026;18(10):e117278
Semaglutide in type 2 diabetes and chronic kidney disease in Australia: practical clinical considerations from a multidisciplinary panel
Internal medicine journal, 2026
Accuracy of Water Intake During Simulated Administration of Oral Semaglutide
Diabetes, obesity & metabolism, 2026